Form 4: Merck Director Paul Rothman Acquires Over 2,800 Phantom Stock Units

Merck & Co., Inc. Director Paul Rothman reported the acquisition of 2,863.0921 phantom stock units on May 30, 2025, as part of a deferred compensation plan.

Summary

• Paul Rothman, a Director at Merck & Co., Inc. (MRK), acquired 2,863.0921 phantom stock units.
• The transaction occurred on May 30, 2025.
• The phantom stock units were acquired at a price of $76.84 per unit.
• Following this transaction, Mr. Rothman's beneficial ownership of phantom stock units increased to 31,990.803 units.
• These phantom stock units are to be settled 100% in cash upon Mr. Rothman's termination of service, in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
• Holdings also include shares acquired in dividend reinvestment transactions.

Sentiment

Score: 7

Explanation: The acquisition of phantom stock units by a director, even if cash-settled, generally indicates continued alignment with the company's performance and is a positive signal regarding insider confidence, especially when part of a compensation plan.

Positives

• The acquisition of phantom stock units by a director indicates continued alignment of interests with shareholders, as the value of these units is tied to the company's stock performance.
• The transaction is part of a structured deferred compensation plan, suggesting a long-term commitment from the director.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The acquisition of phantom stock units by a director aligns their interests with shareholder value, as the value of these units is tied to the company's stock price, even if cash-settled.

Key Dates

Recommendation

Keywords

Merck & Co., MRK, Paul Rothman, SEC Form 4, Insider Transaction, Phantom Stock, Director Compensation, Deferred Compensation, Beneficial Ownership